Diploma in Pharmacovigilance - MedDRA, Causality & Reporting

Turn on real-time data and management reports. Adopt AI-driven vendor-managed inventory and deep learning forecasts with CNN and LSTM to prevent shortages and cut costs.

Explore how the US, EU, and India regulate medical devices through risk-based classification, QMS, clinical trials, and market access steps from registration to post-market surveillance.

learn the duty of candor: a legal and ethical framework for open, honest, transparent reporting of notifiable incidents, five core steps, a 10-day notification, and building a culture of safety.

Explore the good clinical practice and pharmacovigilance regulatory framework guiding drug discovery to post-marketing surveillance, including IND, NDA, GCP, PSUR, and risk management.

Explore how pharmacovigilance detects and prevents drug-related harms through MedDRA coding, causality assessment, and rapid reporting, including case studies and global guidelines like ICH E2A/E2B/E2C.

Explore the evolution of drug safety and pharmacovigilance, from 19th-century anesthesia to modern adverse event reporting, and learn how AE, ADR, serious vs severe, MedDRA, and signals drive post-marketing safety.

Master safe prescribing in the emergency department by decoding illegible handwriting and avoiding dangerous abbreviations. Apply BPMH, PBS rules, and high-risk protocols to protect patients.

Explore how health data becomes a high-stakes target in the AI era, examining data breaches, algorithmic bias, and the zero-trust approach paired with patient engagement to safeguard privacy and ethics.

Leverage real-time data and management reports to optimize the pharmacy supply chain, implement ai-driven vendor-managed inventory, and forecast demand with cnn and lstm models to prevent shortages.

Explore how descriptive, predictive, and prescriptive analytics drive proactive patient care by turning data into actionable decisions, while addressing data quality, privacy, and interoperability.